The study authors explored whether exposure to opioids and benzodiazepines in emergency traumatic injury care is associated with long-term substance use and negative mental health outcomes.
Investigators examined the ability of a diagnostic instrument to differentiate opioid use for pain relief from drug use motives.
Despite some progress in expanding access to medications to treat opioid use disorder, a substantial gap between OUD prevalence and treatment receipt still exists.
Researchers also reviewed demographic associations with opioid prescriptions following ophthalmic procedures.
A lower default number of doses for opioid prescriptions in electronic health record systems does not appear to impact pain control among teens and young adults undergoing tonsillectomy.
Considerable racial and ethnic disparities are seen in drug overdose rates.
Adults with cerebral palsy and spina bifida (CP/SB) obtain significantly higher prescription dosages of opioids than adults without CP/SB.
Project reduced mean pain scores in trauma patients on medication-assisted therapy for opioid use disorder by nearly 50%.
Pain and addiction specialists discuss the rise in workplace violence over opioid denials and how to improve communication and change patient expectations.
RoxyBond is an abuse-deterrent formulation of immediate-release oxycodone that features a unique abuse-deterrent technology.